Indivior Pharmaceuticals, Inc. INDV Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's accounts receivable?
- Indivior Pharmaceuticals, Inc. (INDV) reported accounts receivable of $273M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's accounts receivable changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's accounts receivable increased by 12.3% year-over-year, from $243M to $273M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's accounts receivable?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's accounts receivable has grown at a 261.9% compound annual growth rate (CAGR), from $21M to $995M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.